SB 5416 - DIGEST

(SUBSTITUTED FOR - SEE 1ST SUB)

     Requires identification of drug-affected infants and providing treatment services to their mothers.

     Directs the Washington institute for public policy to evaluate the outcomes of this act and report its findings to the legislature and governor not later than December 1, 2003.  The evaluation shall include:

     (1) The number of women who use nonprescription controlled substances during pregnancy and give birth to drug-affected infants;

     (2) The number of women who use nonprescription controlled substances during pregnancy and give birth to subsequent drug-affected infants;

     (3) The number of women who accept pharmaceutical pregnancy prevention while in chemical dependency treatment;

     (4) The number of women who continue to engage in pharmaceutical pregnancy prevention or other reliable pregnancy prevention methods after concluding chemical dependency treatment;

     (5) The number of women who accept the offer of free tubal ligation;

     (6) The rate of successful completion of chemical dependency treatment among women who enter treatment under this act;

     (7) The number of dependencies filed and deferred under this act and outcomes of the deferrals; and

     (8) A description of the mother's chemical dependency including identification of the drugs and/or alcohol abused.

     Repeals RCW 18.57.930, 18.71.960, 18.79.904, 70.96A.330 and 70.96A.340.